Common Contracts
2 similar null contracts by Virios Therapeutics, Inc.
DOGWOOD THERAPEUTICS FAQ (10/7/24) What was announced?Virios Therapeutics, Inc. • October 7th, 2024 • Pharmaceutical preparations
● Virios Therapeutics, Inc. (“Virios”) and Sealbond Limited (“Sealbond”), an indirect parent of Wex Pharmaceuticals, Inc. (“Wex”), have entered into a definitive share exchange agreement pursuant to which the companies will combine in an all-stock transaction (the “Combination”).
DOGWOOD THERAPEUTICS FAQ (10/7/24) What was announced?Virios Therapeutics, Inc. • October 7th, 2024 • Pharmaceutical preparations
● Virios Therapeutics, Inc. (“Virios”) and Sealbond Limited (“Sealbond”), an indirect parent of Wex Pharmaceuticals, Inc. (“Wex”), have entered into a definitive share exchange agreement pursuant to which the companies will combine in an all-stock transaction (the “Combination”).
